Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXIS™, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com.


SOSV

Cantos

IndieBio

Plug and Play

Civilization Ventures

Khosla Ventures

True Ventures

Celesta Capital

Black Diamond Ventures

Avidity Partners

Lucas Venture Group

Prellis Biologics

Cloudflare Hosting

Person Schema

Cloudflare JS

CDN JS

BootstrapCDN

jQuery CDN

PostalAddress Schema

Fastly

Google Cloud Iowa

Parcel

Chief Scientific Officer

Kevin Chapman

Business Management

Melanie M.

Vice President & Head of Business Development

Alexander Steiner

Vice President, Pre-Clinical Programs and Therapeutic Development

Eric Schoenmakers

Anna Lee

Director of Tissue Engineering

Bhushan Mahadik

Sr. Director of Engineering

Brian Hachtmann

Sr. Director, Chemistry

Randall Lowe

Director of Consumables

Shao Ning Pei

Development Engineer

Alison Pinto

James Rothman

Lei Meng

Michael Marks

Melanie Matheu

CO-Founder & CTO

Michael Nohaile

Hoang Nguyen

Intern

Andrew McFarland

Senior Vice President, Technology

Oleg Konings

Senior Software Engineer

Risa Patterson

Graphic Designer

Mackinley Kath

Optical Engineer

Cantos Portfolio Companies

Micro VC Funded Companies (Top 10K)

San Francisco Bay Area Startups Founded in 2016

West Coast Companies With Fewer Than 1000 Employees (Top 10K)

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

The company was founded in 2016 and is based in San Francisco, California.

Series C - Prellis Biologics

Series B - Prellis Biologics

Convertible Note - Prellis Biologics

Series A - Prellis Biologics

Seed Round - Prellis Biologics

Computer and Software Products and Electrical and Scientific Products

Berkeley

California

United States

North America

Scientist/Sr.Scientist-Immunology job with Prellis Biologics, Inc. | 2910680

Flow Cytometry Specialist job with Prellis Biologics, Inc. | 2903715

Shreyas Gaikwad on LinkedIn: #neopurposetherapeutics #organonchips #bioprinting #oncologystartups

Global Organoids and Spheroids Market Analysis & Forecast 2024-2034, Featuring Prellis Biologics, 3D Biomatrix ...

3D Bioprinting Market is Expected to Reach $3.3 billion | MarketsandMarkets.

Three-dimensional synthetic lymphoid organs and organoids for antibody design …

Three-dimensional bio-engineered lymphoid organs and organoids for cell-based …

Prellis Biologics aims to eliminate the wait list for human organ transplants and speed up development of vital new drug therapies. Using innovations in 3D printing and stem cell development, Prellis can create tissue and organs with the microvascular systems that are critical for supporting viable human tissue. The company offers a platform that recreates human immunobiology using 3D printed lymph node organoids for antibody discovery and immunogenicity assessment.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	99b249cd
crunchbase profile	general	Oct 29, 2024 5:44 AM	867b9045
li profile	general	Jan 29, 2024 11:52 PM	55cd977b
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	a32f75fd
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PRELLISBIO

Prellis Biologics